Téllez-Díaz TJA, Aragón-Castro MA, Vázquez-Niño LC, Gutiérrez-Rosales R, Ruvalcaba-Oceguera GE, Guerrero-Reyes G

Language: Spanish
References: 29
Page: 411-418
PDF size: 308.91 Kb.

ABSTRACT

Stress urinary incontinence is defined by the International Continence Society as the involuntary leakage of urine upon physical effort or exertion, coughing, or sneezing. It has a 49% prevalence in the female population. Age, pregnancy, parity, a history of hysterectomy, obesity, and a history of pelvic radiation are among the risk factors involved in this pathology. Numerous therapeutic strategies for stress urinary incontinence have been described, from conservative management with bladder training to lifestyle changes and surgery. Current first-line management for stress urinary incontinence is the mid-urethral sling, considered the criterion standard, in comparison with other surgical techniques. Corrective treatment is important for improving quality of life in women that present with stress urinary incontinence.

REFERENCES

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37-49.

2. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010; 21:5-26.

3. Kalejaiye O, Vij M, Drake MJ. Classification of stress urinary incontinence. World J Urol 2015; 33:1215-1220.

4. Wood L, Anger J. Urinary incontinence in women. BMJ 2014;349:1-11.

5. Lavelle E, Zyczynski H. Stress Urinary Incontinence Comparative Efficacy Trials. Obstet Gynecol Clin N Am 2016;43:45-57.

6. Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009;360(5):481-90.

7. Danforth KN, Townsend MK, Lifford K, et al. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 2006;194(2):339-45.

8. Dumoulin C, Hay-Smith EJ, Mac Habee-Seguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2014;(5):CD005654.

9. Labrie J, Berghmans BL, Fischer K, et al. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med 2013;369(12):1124-33.

10. Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 2010;115(3):609-617.

11. Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol 2010;183:1906-14.

12. Bing MH, Gimbel H, Greisen S. Clinical risk factors and urodynamic predictors prior to surgical treatment for stress urinary incontinence: a narrative review. Int Urogynecol J 2015;26:175-185.

13. FDA safety communication: urogynecologic surgical mesh, urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. [en línea]. Dirección URL: < https://www.fda. gov/downloads/medicaldevices/safety/alertsandnotices/ ucm262760.pdf >.

14. Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 2010;362(22):2066-76.

15. Albo ME, Litman HJ, Richter HE, et al. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol 2012;188(6):2281-2287.

16. Kenton K, Stoddard AM, Zyczynski H, et al. 5-year longitudinal followup after retropubic and transobturator mid urethral slings. J Urol 2015;193(1):203-10.

17. Brubaker L, Norton PA, Albo ME, et al. Adverse events over two years after retro- pubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol 2011;205(5):498.e1-e6.

18. Schimpf MO, Rahn DD, Wheeler TL, et al. Sling surgery for stress urinary incontinence in women: a systematic review and metaanalysis. Am J Obstet Gynecol 2014;211(1):71.e1-e27.

19. Brown JS, Bradley CS, Subak LL, et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med 2006;144:715-23.

20. Schellart RP, Oude Rengerink K, Van der Aa F, et al. A randomized comparison of a single-incision midurethral sling and a transobturator midurethral sling in women with stress urinary incontinence: results of 12-mo follow-up. Eur Urol 2014;66(6):1179-85.

21. Lee JK, Rosamilia A, Dwyer PL, et al. Randomized trial of a single incision versus an outside-in transobturator midurethral sling in women with stress urinary incontinence: 12 month results. Am J Obstet Gynecol 2015;213(1):35.e1-e9.

22. Mainprize TC, Drutz HP. The Marshall-Marchetti-Krantz procedure: a critical review. Obstet Gynecol Surv 1988;43:724-9.

23. DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 1994;170:1713-20.

24. Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2009;(4):CD006375.

25. Davis N, Kheradmand F, Creagh T. Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents. Int Urogynecol J 2013;24:913-9.

26. Zoorob D, Karram M. Bulking agents: a urogynecology perspective. Urol Clin North Am 2012;39:273-7.

27. Thomas K, Venn SN, Mundy AR. Outcome of the artificial urinary sphincter in female patients. J Urol 2002; 167: 1720–2.

28. Vayleux B, Rigaud J, Luyckx F, et al. Female urinary incontinence and artificial urinary sphincter: study of efficacy and risk factors for failure and complications. Eur Urol 2011;59:1048-53.

29. Lin CS, Lue TF. Stem cell therapy for stress urinary incontinence: a critical review. Stem Cells Dev 2012; 21: 834–43.